ADT vs MSA

ADT's Advanced Deterministic Scorecard reveals a mixed profile: the Piotroski F-Score of 4/9 indicates borderline financial health, while the absence of an Altman Z-Score prevents a clear distress risk assessment. Despite solid profitability metrics—such as a 25.65% operating margin and 17.24% ROE—concerns persist due to weak liquidity (Current Ratio: 0.67, Quick Ratio: 0.37) and high leverage (Debt/Equity: 2.16). The stock trades below the analyst target price of $9.48 and near the Graham Number of $8.48, suggesting modest value, but growth is moderate and insider sentiment is neutral. Technical trend is bearish, and recent price performance shows weakness over the past six months despite a strong 1-year earnings surprise record.

MSA exhibits a stable deterministic health profile with a Piotroski F-Score of 4/9 and exceptional liquidity (Current Ratio 3.01), yet it faces a severe valuation disconnect. The stock trades at a significant premium to its Graham Number ($74.76) and Intrinsic Value ($49.63), suggesting the market is pricing in a high-quality moat that current growth rates (Revenue Growth 2.20%) do not fully justify. While profitability metrics (ROE 22.22%) and a consistent track record of earnings beats are strong, the combination of bearish technicals, insider selling, and stagnant YoY earnings growth warrants a neutral stance.